ciprofloxacin has been researched along with Agranulocytosis in 32 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Agranulocytosis: A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fifty-three granulocytopenic patients were studied in a randomized trial comparing trimethoprim-sulfamethoxaxole (ST) alone with ST + ciprofloxacin (CPFX) for prevention of bacterial infections." | 9.08 | [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin]. ( Murase, T, 1995) |
| " The use of monotherapy with intravenous ciprofloxacin (200 to 300 mg every 12 h) was evaluated against combined therapy with piperacillin plus amikacin in febrile granulocytopenic patients with solid tumor or lymphoma." | 9.07 | Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer ( Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH, 1991) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 9.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "This study developed further clinical experience in using a single agent ("monotherapy") as empirical treatment for neutropenic patients with fever, and compared the safety and toxicity of two candidate agents, ceftazidime and ciprofloxacin." | 9.06 | A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. ( Bayston, KF; Cohen, J; Want, S, 1989) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 9.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "Ciprofloxacin was compared to ciprofloxacin plus amoxicillin as antibacterial prophylaxis in 53 evaluable patients with neutropenic episodes, because an oral penicillin may help to decrease the incidence of gram-positive infections." | 6.67 | Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin. ( Bosi, A; Ciolli, S; Donnini, E; Fanci, R; Guidi, S; Leoni, F; Longo, G; Rossi Ferrini, P, 1993) |
| " Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 5.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
| "The optimal approach to reduce bacterial infections in granulocytopenic patients is still controversial." | 5.28 | [Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer]. ( Gerain, J; Leleux, A; Libert, J; Meunier, F; Snoeck, R, 1989) |
| "In low-risk patients with cancer who have fever and granulocytopenia, oral therapy with ciprofloxacin plus amoxicillin-clavulanate is as effective as intravenous therapy." | 5.09 | Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can ( Cometta, A; De Bock, R; Gaya, H; Kern, WV; Langenaeken, J; Paesmans, M, 1999) |
| "Fifty-three granulocytopenic patients were studied in a randomized trial comparing trimethoprim-sulfamethoxaxole (ST) alone with ST + ciprofloxacin (CPFX) for prevention of bacterial infections." | 5.08 | [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin]. ( Murase, T, 1995) |
| " The use of monotherapy with intravenous ciprofloxacin (200 to 300 mg every 12 h) was evaluated against combined therapy with piperacillin plus amikacin in febrile granulocytopenic patients with solid tumor or lymphoma." | 5.07 | Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer ( Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH, 1991) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 5.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "This study developed further clinical experience in using a single agent ("monotherapy") as empirical treatment for neutropenic patients with fever, and compared the safety and toxicity of two candidate agents, ceftazidime and ciprofloxacin." | 5.06 | A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever. ( Bayston, KF; Cohen, J; Want, S, 1989) |
| "In a multicenter, randomized clinical trial, the efficacy of ciprofloxacin plus azlocillin was compared with that of a standard regimen of ceftazidime plus amikacin for the initial empiric treatment of fever in neutropenic cancer patients." | 5.06 | Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. ( Arnow, P; Edlin, B; Flaherty, JP; George, D; O'Keefe, P; Waitley, D; Weinstein, RA, 1989) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 5.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "Forty-six episodes of fever in 34 patients with neutropenia and haematological malignancy were treated empirically with a combination of ciprofloxacin and vancomycin." | 3.67 | A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1988) |
| "Twenty-four episodes of fever in neutropenic patients with haematological malignancy were treated with ciprofloxacin." | 3.67 | Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1986) |
| "Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients." | 2.67 | Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. ( Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM, 1994) |
| "Ciprofloxacin was compared to ciprofloxacin plus amoxicillin as antibacterial prophylaxis in 53 evaluable patients with neutropenic episodes, because an oral penicillin may help to decrease the incidence of gram-positive infections." | 2.67 | Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin. ( Bosi, A; Ciolli, S; Donnini, E; Fanci, R; Guidi, S; Leoni, F; Longo, G; Rossi Ferrini, P, 1993) |
| " Serious adverse reactions reported with ciprofloxacin are rare with an incidence of 0." | 1.35 | Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin. ( Ruxana, K; Upadya, GM, 2009) |
| "We report a case of agranulocytosis which developed 3 weeks after onset of acute hepatitis B in an HIV-positive patient." | 1.31 | [Agranulocytosis in acute hepatitis B in an HIV seropositive patient]. ( Brazille, P; Coutant-Perronne, V; Malkin, JE; Raguin, G, 2000) |
| "The optimal approach to reduce bacterial infections in granulocytopenic patients is still controversial." | 1.28 | [Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer]. ( Gerain, J; Leleux, A; Libert, J; Meunier, F; Snoeck, R, 1989) |
| "Ciprofloxacin was studied in vitro and in an experimental thigh infection model in mice to evaluate its efficacy against Pseudomonas aeruginosa in comparison with that of tobramycin." | 1.27 | The activity of ciprofloxacin against Pseudomonas aeruginosa in normal and granulocytopenic mice. ( Hoogeterp, JJ; Mattie, H; Terporten, P, 1987) |
| "Ciprofloxacin was studied in vitro and in an experimental thigh infection model in mice to evaluate its efficacy against Pseudomonas aeruginosa in comparison with that of tobramycin." | 1.27 | The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice. ( Hoogeterp, JJ; Mattie, H; Terporten, P, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (59.38) | 18.7374 |
| 1990's | 10 (31.25) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Upadya, GM | 1 |
| Ruxana, K | 1 |
| Murase, T | 1 |
| D'Antonio, D | 2 |
| Piccolomini, R | 1 |
| Iacone, A | 1 |
| Fioritoni, G | 1 |
| Parruti, G | 1 |
| Betti, S | 1 |
| Quaglietta, AM | 1 |
| Accorsi, P | 1 |
| Dell'Isola, M | 1 |
| Favalli, C | 1 |
| Fanci, R | 1 |
| Leoni, F | 1 |
| Bosi, A | 1 |
| Guidi, S | 1 |
| Ciolli, S | 1 |
| Longo, G | 1 |
| Donnini, E | 1 |
| Rossi Ferrini, P | 1 |
| Kern, WV | 1 |
| Cometta, A | 1 |
| De Bock, R | 1 |
| Langenaeken, J | 1 |
| Paesmans, M | 1 |
| Gaya, H | 2 |
| Cambon, S | 1 |
| Rossi, P | 1 |
| Miliani, Y | 1 |
| Arnaud, S | 1 |
| Albanèse, J | 1 |
| Brazille, P | 1 |
| Coutant-Perronne, V | 1 |
| Malkin, JE | 1 |
| Raguin, G | 1 |
| Giamarellou, H | 1 |
| Bassaris, HP | 1 |
| Petrikkos, G | 1 |
| Busch, W | 1 |
| Voulgarelis, M | 1 |
| Antoniadou, A | 1 |
| Grouzi, E | 1 |
| Zoumbos, N | 1 |
| Krcméry, V | 1 |
| Fuchsberger, P | 1 |
| Trupl, J | 1 |
| Sufliarsky, J | 1 |
| Spanik, S | 1 |
| Koza, I | 1 |
| Kusenda, Z | 1 |
| Korec, S | 1 |
| Svec, J | 1 |
| Durkovic, P | 1 |
| Donnelly, JP | 2 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| Meunier, F | 2 |
| Zinner, SH | 1 |
| Calandra, T | 1 |
| Viscoli, C | 1 |
| Klastersky, J | 1 |
| Glauser, M | 1 |
| Opal, SM | 1 |
| Cross, AS | 1 |
| Kelly, NM | 1 |
| Sadoff, JC | 1 |
| Bodmer, MW | 1 |
| Palardy, JE | 1 |
| Victor, GH | 1 |
| Dekker, AW | 2 |
| Rozenberg-Arska, M | 2 |
| Verdonck, LF | 1 |
| Del Favero, A | 1 |
| Martino, P | 1 |
| Bucaneve, G | 1 |
| Micozzi, A | 1 |
| Minetti, B | 1 |
| Ricci, P | 1 |
| Landonio, G | 1 |
| Montillo, M | 1 |
| Malleo, C | 1 |
| Kelsey, SM | 1 |
| Wood, ME | 1 |
| Shaw, E | 1 |
| Newland, AC | 1 |
| Weers-Pothoff, G | 1 |
| Novakova, IR | 1 |
| Muytjens, HL | 1 |
| Snoeck, R | 1 |
| Gerain, J | 1 |
| Leleux, A | 1 |
| Libert, J | 1 |
| Chan, CC | 1 |
| Oppenheim, BA | 1 |
| Anderson, H | 1 |
| Swindell, R | 1 |
| Scarffe, JH | 1 |
| Bayston, KF | 1 |
| Want, S | 1 |
| Cohen, J | 1 |
| Flaherty, JP | 1 |
| Waitley, D | 1 |
| Edlin, B | 1 |
| George, D | 1 |
| Arnow, P | 1 |
| O'Keefe, P | 1 |
| Weinstein, RA | 1 |
| Hoogeterp, JJ | 3 |
| Mattie, H | 3 |
| Krul, AM | 1 |
| Terporten, P | 3 |
| van Furth, R | 1 |
| Bendig, JW | 1 |
| Kyle, PW | 1 |
| Giangrande, PL | 1 |
| Samson, DM | 1 |
| Azadian, BS | 1 |
| Mannan, P | 1 |
| Kibbler, CC | 1 |
| Noone, P | 1 |
| Gordin, FM | 1 |
| Hackbarth, CJ | 1 |
| Scott, KG | 1 |
| Sande, MA | 1 |
| Trautmann, M | 1 |
| Brückner, O | 1 |
| Marre, R | 1 |
| Hahn, H | 1 |
| Dennig, D | 1 |
| Fülle, HH | 1 |
| Hellriegel, KP | 1 |
| Smith, GM | 2 |
| Leyland, MJ | 2 |
| Farrell, ID | 2 |
| Geddes, AM | 2 |
| Verhoef, J | 1 |
| Fu, KP | 1 |
| Hetzel, N | 1 |
| Gregory, FJ | 1 |
| Hung, PP | 1 |
14 trials available for ciprofloxacin and Agranulocytosis
| Article | Year |
|---|---|
[Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infect | 1995 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin | 1994 |
Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Amoxicillin; Bacteria; Bacterial Infections; Ciprofloxacin | 1993 |
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Amoxici | 1999 |
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.
Topics: Administration, Oral; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefta | 2000 |
Ciprofloxacin plus vancomycin versus ceftazidime plus gentamicin in the treatment of pneumonia in granulocytopenic patients with or without venous catheters. Short communication.
Topics: Adult; Agranulocytosis; Bronchopneumonia; Catheterization; Ceftazidime; Ciprofloxacin; Drug Therapy, | 1992 |
Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Colistin; Drug Therap | 1992 |
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug | 1991 |
[Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transplantation; Ciproflox | 1989 |
Intravenous ciprofloxacin as empirical treatment of febrile neutropenic patients.
Topics: Adult; Agranulocytosis; Bacteria; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Fe | 1989 |
Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bone Marrow Tr | 1989 |
A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with fever.
Topics: Adolescent; Adult; Agranulocytosis; Bacterial Infections; Ceftazidime; Ciprofloxacin; Female; Fever; | 1989 |
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazi | 1989 |
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Dr | 1987 |
18 other studies available for ciprofloxacin and Agranulocytosis
| Article | Year |
|---|---|
Toxic epidermal necrolysis and agranulocytosis: rare adverse effects of ciprofloxacin.
Topics: Administration, Oral; Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Ciproflo | 2009 |
[Severe agranulocytosis induced by carbamazepine (Tegretol)].
Topics: Acinetobacter Infections; Adult; Agranulocytosis; Analgesics, Non-Narcotic; Anti-Bacterial Agents; A | 1999 |
[Agranulocytosis in acute hepatitis B in an HIV seropositive patient].
Topics: Acute Disease; Adult; Agranulocytosis; Anti-HIV Agents; Ciprofloxacin; Diagnosis, Differential; Drug | 2000 |
Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa.
Topics: Agranulocytosis; Animals; Antibodies, Monoclonal; Ciprofloxacin; Combined Modality Therapy; Disease | 1990 |
Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Topics: Acute Disease; Adult; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocol | 1990 |
Bacteraemia caused by Stomatococcus mucilaginosus in a granulocytopenic patient with acute lymphocytic leukaemia.
Topics: Adult; Agranulocytosis; Amsacrine; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Proto | 1989 |
[Prevention of bacterial infections using ciprofloxacin in granulocytopenic patients with cancer].
Topics: Adolescent; Adult; Aged; Agranulocytosis; Antineoplastic Agents; Bacterial Infections; Ciprofloxacin | 1989 |
Comparison of in vivo and in vitro activities of antibiotics with different modes of action against a tolerant and a non-tolerant Staphylococcus aureus strain.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Mice; Penicillin | 1989 |
Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
Topics: Adolescent; Aged; Agranulocytosis; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; | 1987 |
The activity of ciprofloxacin against Pseudomonas aeruginosa in normal and granulocytopenic mice.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aerugi | 1987 |
The relative efficacies of tobramycin and ciprofloxacin against Pseudomonas aeruginosa in vitro and in normal and granulocytopenic mice.
Topics: Agranulocytosis; Animals; Ciprofloxacin; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobra | 1988 |
Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.
Topics: Agranulocytosis; Ciprofloxacin; Colistin; Drug Resistance, Microbial; Humans; Microbial Sensitivity | 1988 |
Activities of pefloxacin and ciprofloxacin in experimentally induced Pseudomonas pneumonia in neutropenic guinea pigs.
Topics: Agranulocytosis; Animals; Anti-Bacterial Agents; Ciprofloxacin; Guinea Pigs; Half-Life; Microbial Se | 1985 |
Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
Topics: Agranulocytosis; Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combinat | 1988 |
Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Bacterial Infections; Ciprof | 1987 |
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; L | 1988 |
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Female; Fever; Half-Life; Humans; | 1986 |
Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Topics: Agranulocytosis; Animals; Cephalosporins; Ciprofloxacin; Cyclophosphamide; Drug Therapy, Combination | 1987 |